Evaluate Efficacy, Safety, Tolerability and Biodegradation of PA5346 Ocular Implant in Patients With Open-Angle Glaucoma or Ocular Hypertension

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(3 sites)

Australia

Cataract & Eye Surgery Centre, Doncaster, Victoria

Cerulea Pty Ltd, East Melbourne, Victoria

Melbourne Eye Specialists, Melbourne, Victoria